查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1716421

2032 年筆式針頭市場預測：按類型、針頭長度、分銷管道、應用、最終用戶和地區進行的全球分析

Pen Needles Market Forecasts to 2032 - Global Analysis By Type (Standard Pen Needles, Safety Pen Needles, Short Pen Needles, Long Pen Needles, and Other Types), Needle Length, Distribution Channel, Application, End Users and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球注射筆針頭市場預計在 2025 年達到 24.8 億美元，預計到 2032 年將達到 45.4 億美元，預測期內的複合年成長率為 9.0%。

筆針是一種小型、空心、中空的針，設計用於與胰島素筆或其他注射器一起使用，以精確和可控的方式輸送胰島素或其他藥物。它們具有多種長度和規格，以滿足不同患者的需求，確保舒適有效的注射。糖尿病患者通常使用注射筆透過皮下注射胰島素來控制病情。它也用於實施其他注射療法，提供便利性並減少對注射器的需求。

根據Ipsomed在2023年11月發布的數據，該公司注射筆Uno Pen和Ipsopen的需求在過去幾年中顯著成長，其中Uno（現為MTD Medical Technology and Devices SpA的一部分）注射筆的銷量超過1億支，Ipsopen的銷量超過1000萬支。

家庭醫療保健的普及率提高

老年人口的不斷成長和糖尿病盛行率的上升推動了使用注射筆針頭自行注射胰島素的需求。針頭設計的進步，包括更細、更短的針頭，提高了患者的舒適度和對胰島素治療的依從性。此外，從傳統注射器到胰島素筆的轉變提高了劑量的準確性和易用性，進一步推動了市場的成長。政府推動居家醫療和擴大遠端醫療服務的措施也支持了這一趨勢。

缺乏培訓和意識

操作或給藥技術不當可能導致針刺傷、感染疾病、血糖控制不佳。在開發中地區，糖尿病教育計畫的有限性加劇了這個問題，導致患者對胰島素治療的依從性較差。此外，對使用注射筆引起的疼痛和不適的誤解可能會使一些患者不願意使用注射筆。低收入地區的醫療保健系統通常缺乏有關胰島素輸送裝置的結構化培訓計劃。解決這些教育差距對於充分發揮注射筆在糖尿病管理中的潛力至關重要。

提高糖尿病管理意識

國際糖尿病聯盟 (IDF) 等組織發起的公共衛生宣傳活動和舉措正在提高人們對現代胰島素給藥方法的認知。安全設計的針筆等技術進步因其能夠減少針刺傷害並提高患者安全性而獲得支持。智慧胰島素筆等數位健康工具的整合，透過追蹤劑量和提供提醒，進一步增強了糖尿病管理。糖尿病盛行率不斷上升的新興市場為市場擴張提供了尚未開發的潛力。

針刺傷風險

不當處置和處理用過的針頭可能會導致意外針刺，增加傳播愛滋病毒和肝炎等感染疾病的風險。監管機構已加強了針頭安全的指導方針，但各地區的遵守情況有所不同。此外，安全設計的筆針價格昂貴，限制了其在資源匱乏的環境中的應用。進一步加劇問題的是，患者由於認為安全機制很複雜而不願意使用安全機制。應對這些挑戰需要不斷創新針頭設計並加強安全通訊協定的執行。

COVID-19的影響：

COVID-19 疫情以多種方式影響了針筆市場，供應鏈中斷和醫院就診人數減少最初減緩了成長。然而，封鎖期間對家庭糖尿病管理的重視程度增加，導致對胰島素筆和筆針的需求增加。患者傾向於自我給藥以避免頻繁去醫院，從而降低接觸風險。疫情過後，對慢性病管理和預防性醫療保健的重視將繼續推動市場擴張。製造商現在優先考慮有彈性的供應鏈和數位健康整合，以滿足不斷變化的患者需求。

預計安全筆針頭市場在預測期內將佔據最大佔有率

由於嚴格的監管準則提倡預防醫療環境中的針刺傷，因此預計安全針頭部分將在預測期內佔據最大的市場佔有率。可伸縮針頭、自動屏蔽機制和被動安全設計等創新為用戶，尤其是醫護人員和家庭看護者提供了更大的保護。人們對無痛超細針頭的偏好日益成長，進一步推動了糖尿病患者的採用。此外，已開發地區針對安全設計設備的報銷政策不斷增加，有助於推動市場發展。

預計在預測期內，醫院部門的複合年成長率最高。

由於糖尿病住院人數增加以及臨床環境中胰島素筆的使用增加，醫院部門預計將在預測期內實現最高成長。電子健康記錄(EHR) 和智慧胰島素筆的整合增強了藥物依從性和監測。此外，政府推動醫院糖尿病護理標準化的舉措以及基於價值的醫療保健日益成長的趨勢也促進了該領域的成長。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率。這是在印度和中國等國家糖尿病盛行率高且不斷上升的背景下發生的。醫療保健支出的增加、政府主導的糖尿病意識計劃以及胰島素輸送設備獲取途徑的改善正在支持市場的成長。該地區遠端醫療和家庭醫療保健服務的擴展進一步推動了對注射筆針頭的需求。此外，本地製造商正在推出具有成本效益的產品，使更多患者能夠使用。

複合年成長率最高的地區：

預計北美地區在預測期內將呈現最高的複合年成長率。這是由於先進的醫療保健基礎設施、安全筆針的廣泛採用以及對針刺傷害預防的強力的監管支持。由於糖尿病管理設備的醫療保險覆蓋範圍廣泛且患者意識不斷增強，美國在該地區市場佔據主導地位。聯網胰島素筆和人工智慧劑量追蹤等技術進步正日益普及。此外，對糖尿病研究和數位健康解決方案的投資不斷增加也促進了市場的發展。

提供免費客製化：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章 全球筆針市場（按類型）

  • 標準筆針
  • 安全筆針
  • 短筆針
  • 長筆針
  • 其他類型

6. 全球注射筆針頭市場（依針頭長度）

  • 短款
  • 中型長度
  • 長款

7. 全球注射筆針市場（依通路）

  • 零售藥局
  • 直銷
  • 網上銷售
  • 醫療設備經銷商
  • 其他分銷管道

8. 全球注射筆針頭市場（依應用）

  • 糖尿病治療
  • 生長激素荷爾蒙療法
  • 不孕不育治療
  • 其他用途

9. 全球注射筆針頭市場（按最終用戶）

  • 醫院
  • 診所
  • 居家護理
  • 門診手術中心（ASC）
  • 其他最終用戶

第 10 章全球筆針市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Novo Nordisk
  • Shanghai United Injection Device Co., Ltd.
  • Becton, Dickinson and Company（BD）
  • Ypsomed AG
  • Terumo Corporation
  • Mylan NV
  • Medtronic
  • Owen Mumford
  • Sun Pharma
  • Diabetes Care
  • Roche Holding AG
  • Eli Lilly and Company
  • Smiths Medical
  • Injecto Pharmaceuticals
  • Antares Pharma
Product Code: SMRC29232

According to Stratistics MRC, the Global Pen Needles Market is accounted for $2.48 billion in 2025 and is expected to reach $4.54 billion by 2032 growing at a CAGR of 9.0% during the forecast period. Pen needles are small, hollow, and thin needles designed for use with insulin pens or other injectable devices to administer medications, such as insulin, in a precise and controlled manner. They come in various lengths and gauges to suit different patient needs, ensuring comfortable and effective injections. Pen needles are commonly used by individuals with diabetes to manage their condition by delivering insulin subcutaneously. They are also used in the administration of other injectable treatments, offering convenience and reducing the need for syringes.

According to data published by Ypsomed in November 2023, the demand for its pen injections, UnoPen and YpsoPen, increased significantly in the past years, and sales exceeded 100 million units of Uno (now part of MTD Medical Technology and Devices S.p.A.) Pen and 10 million units of YpsoPen.

Market Dynamics:

Driver:

Rising adoption of home healthcare

The growing elderly population, coupled with the rising prevalence of diabetes, has amplified the demand for self-administration of insulin using pen needles. Advancements in needle design, such as thinner and shorter needles, have improved patient comfort and adherence to insulin therapy. Additionally, the shift from conventional syringes to insulin pens has enhanced dosing accuracy and ease of use, further supporting market growth. Government initiatives promoting home-based care and the expansion of telehealth services have also contributed to this trend.

Restraint:

Lack of training and awareness

Improper handling and administration techniques can lead to needlestick injuries, infections, and suboptimal glycemic control. In developing regions, limited access to diabetes education programs exacerbates this issue, leading to poor adherence to insulin therapy. Additionally, misconceptions about pain and discomfort associated with pen needles discourage some patients from adopting them. Healthcare systems in low-income areas often lack structured training programs for insulin delivery devices. Addressing these educational gaps is crucial to maximizing the potential of pen needles in diabetes management.

Opportunity:

Growing awareness of diabetes management

Public health campaigns and initiatives by organizations like the International Diabetes Federation (IDF) are raising awareness about modern insulin administration methods. Technological advancements, such as safety-engineered pen needles, are gaining traction due to their ability to reduce needlestick injuries and improve patient safety. The integration of digital health tools, including smart insulin pens, further enhances diabetes management by tracking doses and providing reminders. Emerging markets with rising diabetes prevalence offer untapped potential for market expansion.

Threat:

Risk of needlestick injuries

Improper disposal and handling of used needles can lead to accidental punctures, increasing the risk of bloodborne infections such as HIV and hepatitis. Regulatory bodies are enforcing stricter guidelines on needle safety, but compliance varies across regions. The high cost of safety-engineered pen needles also limits their adoption in low-resource settings. Additionally, patient reluctance to use safety mechanisms due to perceived complexity further exacerbates the issue. Addressing these challenges requires continuous innovation in needle design and stronger enforcement of safety protocols.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the pen needles market, with disruptions in supply chains and reduced hospital visits initially slowing growth. However, the increased focus on home-based diabetes management during lockdowns boosted demand for insulin pens and pen needles. Patients preferred self-administration to avoid frequent hospital visits, reducing exposure risks. Post-pandemic, the emphasis on chronic disease management and preventive healthcare continues to drive market expansion. Manufacturers are now prioritizing resilient supply chains and digital health integration to meet evolving patient needs.

The safety pen needles segment is expected to be the largest during the forecast period

The safety pen needles segment is expected to account for the largest market share during the forecast period, driven by stringent regulatory guidelines promoting needlestick injury prevention in healthcare settings. Innovations such as retractable needles, automatic shielding mechanisms, and passive safety designs enhance user protection, particularly for healthcare workers and home caregivers. The growing preference for painless and ultra-thin needles further boosts adoption among diabetes patients. Additionally, increasing reimbursement policies for safety-engineered devices in developed regions support market expansion.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate attributed to the rising number of diabetes-related hospital admissions and the increasing use of insulin pens in clinical settings. The integration of electronic health records (EHRs) with smart insulin pens enhances medication adherence and monitoring. Furthermore, government initiatives to standardize diabetes care in hospitals and the growing trend of value-based healthcare contribute to segment growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by the high and growing prevalence of diabetes in countries like India and China. Increasing healthcare expenditure, government-led diabetes awareness programs, and improving access to insulin delivery devices support market growth. The expansion of telemedicine and home healthcare services in the region further boosts demand for pen needles. Additionally, local manufacturers are introducing cost-effective products, making them accessible to a larger patient population.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare infrastructure, high adoption of safety pen needles, and strong regulatory support for needlestick injury prevention. The U.S. dominates the regional market due to widespread health insurance coverage for diabetes management devices and increasing patient awareness. Technological advancements, such as connected insulin pens and AI-driven dose tracking, are gaining traction. Additionally, rising investments in diabetes research and digital health solutions contribute to market acceleration.

Key players in the market

Some of the key players in Pen Needles Market include Novo Nordisk, Shanghai United Injection Device Co., Ltd., Becton, Dickinson and Company (BD), Ypsomed AG, Terumo Corporation, Mylan N.V., Medtronic, Owen Mumford, Sun Pharma, Diabetes Care, Roche Holding AG, Eli Lilly and Company, Smiths Medical, Injecto Pharmaceuticals, and Antares Pharma.

Key Developments:

In March 2025, Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) announced that Novo Nordisk and TUL's wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd., have entered into an exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon in early-stage clinical development for the treatment of obesity, type 2 diabetes, and other diseases.

In February 2025, Terumo Vietnam Medical Equipment (Terumo Vietnam) and Daiichi Sankyo Vietnam have signed a Memorandum of Understanding (MoU) to collaborate on advancing cardiovascular expertise in Vietnam. The initiative aims to support healthcare professionals in updating their knowledge and skills in interventional cardiology.

Types Covered:

  • Standard Pen Needles
  • Safety Pen Needles
  • Short Pen Needles
  • Long Pen Needles
  • Other Types

Needle Lengths Covered:

  • Short Length
  • Medium Length
  • Long Length

Distribution Channels Covered:

  • Retail Pharmacies
  • Direct Sales
  • Online Sales
  • Medical Distributors
  • Other Distribution Channels

Applications Covered:

  • Diabetes Treatment
  • Growth Hormone Therapy
  • Infertility Treatment
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Surgical Centers (ASCs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pen Needles Market, By Type

  • 5.1 Introduction
  • 5.2 Standard Pen Needles
  • 5.3 Safety Pen Needles
  • 5.4 Short Pen Needles
  • 5.5 Long Pen Needles
  • 5.6 Other Types

6 Global Pen Needles Market, By Needle Length

  • 6.1 Introduction
  • 6.2 Short Length
  • 6.3 Medium Length
  • 6.4 Long Length

7 Global Pen Needles Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacies
  • 7.3 Direct Sales
  • 7.4 Online Sales
  • 7.5 Medical Distributors
  • 7.6 Other Distribution Channels

8 Global Pen Needles Market, By Application

  • 8.1 Introduction
  • 8.2 Diabetes Treatment
  • 8.3 Growth Hormone Therapy
  • 8.4 Infertility Treatment
  • 8.5 Other Applications

9 Global Pen Needles Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Home Care
  • 9.5 Ambulatory Surgical Centers (ASCs)
  • 9.6 Other End Users

10 Global Pen Needles Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Novo Nordisk
  • 12.2 Shanghai United Injection Device Co., Ltd.
  • 12.3 Becton, Dickinson and Company (BD)
  • 12.4 Ypsomed AG
  • 12.5 Terumo Corporation
  • 12.6 Mylan N.V.
  • 12.7 Medtronic
  • 12.8 Owen Mumford
  • 12.9 Sun Pharma
  • 12.10 Diabetes Care
  • 12.11 Roche Holding AG
  • 12.12 Eli Lilly and Company
  • 12.13 Smiths Medical
  • 12.14 Injecto Pharmaceuticals
  • 12.15 Antares Pharma

List of Tables

  • Table 1 Global Pen Needles Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Pen Needles Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Pen Needles Market Outlook, By Standard Pen Needles (2024-2032) ($MN)
  • Table 4 Global Pen Needles Market Outlook, By Safety Pen Needles (2024-2032) ($MN)
  • Table 5 Global Pen Needles Market Outlook, By Short Pen Needles (2024-2032) ($MN)
  • Table 6 Global Pen Needles Market Outlook, By Long Pen Needles (2024-2032) ($MN)
  • Table 7 Global Pen Needles Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 8 Global Pen Needles Market Outlook, By Needle Length (2024-2032) ($MN)
  • Table 9 Global Pen Needles Market Outlook, By Short Length (2024-2032) ($MN)
  • Table 10 Global Pen Needles Market Outlook, By Medium Length (2024-2032) ($MN)
  • Table 11 Global Pen Needles Market Outlook, By Long Length (2024-2032) ($MN)
  • Table 12 Global Pen Needles Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 13 Global Pen Needles Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 14 Global Pen Needles Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 15 Global Pen Needles Market Outlook, By Online Sales (2024-2032) ($MN)
  • Table 16 Global Pen Needles Market Outlook, By Medical Distributors (2024-2032) ($MN)
  • Table 17 Global Pen Needles Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 18 Global Pen Needles Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Pen Needles Market Outlook, By Diabetes Treatment (2024-2032) ($MN)
  • Table 20 Global Pen Needles Market Outlook, By Growth Hormone Therapy (2024-2032) ($MN)
  • Table 21 Global Pen Needles Market Outlook, By Infertility Treatment (2024-2032) ($MN)
  • Table 22 Global Pen Needles Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 23 Global Pen Needles Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Pen Needles Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 25 Global Pen Needles Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 26 Global Pen Needles Market Outlook, By Home Care (2024-2032) ($MN)
  • Table 27 Global Pen Needles Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 28 Global Pen Needles Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.